Covid-19 Impact on Healthcare CRO Market 2021-2025: Business Growth by Top Key Company’s - PAREXEL, Quintiles Transnational Holdings, Laboratory Corporation Of America Holdings, ICON

Overview of Global Healthcare CRO Market:

This report provides in-depth study of “Global Healthcare CRO Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Healthcare CRO Market report also provides an in-depth survey of key players in the market organization.

According to the market research study, Contract Research Organization (CRO) offers support to pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. It mainly provides services for biopharmaceutical development, biologic assay development, commercialization of new entity, preclinical research, clinical research, clinical trials management, and pharmacovigilance.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/261814 .

Some of the most important key factors driving the growth of the Global Healthcare CRO Market are increasing investment in R&D programs, preference for outsourcing activities due to time and cost constraints, and patent expiration in the healthcare sector. Furthermore, Contract Research Organizations (CROs) provide the experience of moving a novel drug, molecule, or a drug from its nascent phase to marketing approval, without any need for a sponsor for these services.

Regionally, North America accounted for the majority of the Healthcare CRO Market share in 2018 and is anticipated to continue this trend during the forecast period. This is attributed to the increased focus of leading companies in the field of biotech and pharmaceutical research. APAC is anticipated to grow at the fastest rate during the forecast period, owing to the rise in focus toward conducting R&D and developing novel products. APAC is considered one of the fastest growing regions in the biotechnology & pharmaceutical market due to increased technological innovations and funding provided by governments and private organizations.

In the end, the report makes some important proposals for a new project of Healthcare CRO Market before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2025 global Healthcare CRO market covering all important parameters.

Global Key Vendors:

1 Quintiles Transnational Holdings

2 Laboratory Corporation Of America Holdings

3 PAREXEL International

4 ICON plc

5 PRA Health Sciences

6 InVentiv Health

7 Charles River Laboratories

8 INC Research Holdings

9 Wuxi PharmaTech and More…………….

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Healthcare CRO Market Report 2021” @ https://www.businessindustryreports.com/buy-now/261814/single .

Product Type Segmentation

1 Early Phase Development

2 Clinical Research

3 Laboratory

4 Consulting Services

Industry Segmentation

1 Biopharmaceutical Companies

2 Academic and Research Institutes

Global Medical Industry News:

Parexel (February 04, 2021) - Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials - Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, and NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a strategic partnership to advance the application of precision medicine in oncology clinical trials by applying real-world genomics data to accelerate patient matching and optimize trial design, site selection, clinical development and translational research.

The collaboration with NeoGenomics will enhance Parexel’s use of real-world data across various applications, including identifying and estimating prevalence of genomic mutations within respective populations, genomic patterning to stratify patients according to novel biomarkers, and use of de-identified patient data to precisely target patient populations. Collectively these data are designed to better inform clinical trial feasibility, enhance patient matching and create a holistic view of the patient journey by linking genomic data with clinical and consumer datasets. The collaboration will ultimately enable researchers to quickly enroll patients with common to rare cancer mutations and connect them to clinical trials providing the best likelihood of potential treatment success.

“Parexel’s partnership with NeoGenomics provides access to greater predictive modeling capabilities so that we can rapidly identify specific patients and connect them to clinical trials that provide them with the best potential for treatment, advance our understanding of their disease and identify the drug’s effects and potential benefits,” said Sy Pretorius, MD, President, Clinical Development and Chief Medical Officer at Parexel. “This collaboration supports our efforts to adopt more novel approaches in the identification of data populations for oncology studies while keeping the patient at the center of everything we do.”

“We are thrilled to collaborate with Parexel to provide our robust genomic and clinical database to help match cancer patients to clinical trials and therapies that are precisely targeted to their unique tumor types and genomic biomarkers,” said Douglas VanOort, NeoGenomics’ Chairman and Chief Executive Officer. “We look forward to our strategic partnership and future opportunities to broaden our relationship based on customer needs in the oncology space.”

The strategic partnership between Parexel and NeoGenomics will enable biopharmaceutical customers to make evidence-based decisions regarding trial designs, companion diagnostics and drug repurposing as well as to build external control arms using genomic data, ultimately providing cancer patients access to the most effective therapies when and where they need them. The companies are considering potential opportunities to expand the scope of the partnership, including lab services and biomarker capabilities.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/261814 .

Major Points in Table of Contents:

Global Healthcare CRO Market Report 2021

1 Healthcare CRO Definition

2 Global Healthcare CRO Market Major Player Share and Market Overview

2.1 Global Major Player Healthcare CRO Business Revenue

2.2 Global Healthcare CRO Market Overview

3 Major Player Healthcare CRO Business Introduction

3.1 Quintiles Transnational Holdings Healthcare CRO Business Introduction

3.2 Laboratory Corporation Of America Holdings Healthcare CRO Business Introduction

3.3 Pharmaceutical Product Development Healthcare CRO Business Introduction

3.4 PAREXEL International Healthcare CRO Business Introduction

3.5 ICON plc Healthcare CRO Business Introduction

3.6 PRA Health Sciences Healthcare CRO Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.